Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07455773

Experimental Study on the Use of Intrauterine Infusion of Autologous Platelet-rich Plasma (PRGF-IUI) in Patients With Recurrent Implantation Failure and/or Refractory Thin Endometrium (PMA_PREPAIRE)

PMA_PREPAIRE STUDY: Experimental Study on the Use of Intrauterine Infusion of Autologous Platelet-rich Plasma (PRGF-IUI) in Patients With Recurrent Implantation Failure and/or Refractory Thin Endometrium.

Sponsor: Azienda Sanitaria Locale di Asti

Conditions Embryo Implantation Endometrial Receptivity Disorders Infertility, Female Platelet-Rich Plasma Platelet-rich Plasma (PRP) Recurrent Implantation Failure

Interventions Hormone Replacement Therapy (HRT) Intrauterine Platelet-Rich Plasma (PRP) Infusion

Updated 1 time since 2026 Last updated: Mar 3, 2026 Started: May 1, 2026 Primary completion: May 1, 2027 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07455773, this NA trial focuses on Embryo Implantation and Endometrial Receptivity Disorders and remains actively recruiting participants. Sponsored by Azienda Sanitaria Locale di Asti, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Sanitaria Locale di Asti

Data source: Azienda Sanitaria Locale di Asti

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.